Transforming growth factor-β secreted from CD4⁺ T cells ameliorates antigen-induced eosinophilic inflammation: A novel high-dose tolerance in the trachea

Medicine and Dentistry

• Transforming Growth Factor 100%
• Drug Megadose 83%
• Ovalbumin 83%
• Serositis 66%
• Antigen 50%
• Eosinophilic 50%
• Trachea 50%
• T Cell 50%
• Autoimmunity 33%
• Mucosal Tissue 33%
• T Helper 1 Cell 33%
• T-Helper Cell 33%
• In Vitro 16%
• Immune Response 16%
• Combination Therapy 16%
• Lymph Node 16%
• Monoclonal Antibody 16%
• Interferon 16%
• Allergy 16%
• Antigen Specificity 16%
• Th2 Cell 16%
• Mediastinal Lymph Node 16%
• Immunostimulation 16%
• down Regulation 16%
• Optimal Drug Dose 16%
• Immunological Tolerance 16%
• Adoptive Transfer 16%
• Interleukin 4 16%
• Lymph Node Cell 16%
• Respiratory Mucosa 16%
• Intratracheal Drug Administration 16%
• Aluminum Hydroxide 16%
• Regulatory Mechanism 16%
• Intestine 16%

Immunology and Microbiology

• Transforming Growth Factor 100%
• Drug Megadose 83%
• Antigen 50%
• Trachea 50%
• Inflammation 50%
• Autoimmunity 33%
• Mouse 33%
• Immune Response 16%
• Monoclonal Antibodies 16%
• Allergy 16%
• CD4 16%
• Modulation 16%
• Th2 Cell 16%
• Antigen Specificity 16%
• Interferon Type I 16%
• Immunostimulation 16%
• Immune Tolerance 16%
• down Regulation 16%
• Bagg Albino Mouse 16%
• Interleukin 4 16%
• Intestine 16%
• Respiratory Mucosa 16%
• Lymph Node Cell 16%
• Regulatory Mechanism 16%
• Optimal Drug Dose 16%